Amgen (AMGN) Net Margin (2016 - 2026)

Amgen has reported Net Margin over the past 18 years, most recently at 21.11% for Q1 2026.

For Q1 2026, Net Margin fell 12.0% year-over-year to 21.11%; the TTM value through Mar 2026 reached 20.96%, up 357.0%, while the annual FY2025 figure was 20.98%, 875.0% up from the prior year.
Net Margin for Q1 2026 was 21.11% at Amgen, up from 13.51% in the prior quarter.
Over five years, Net Margin peaked at 352.07% in Q4 2022 and troughed at 1.52% in Q1 2024.
A 5-year average of 40.07% and a median of 21.11% in 2026 define the central range for Net Margin.
Biggest five-year swings in Net Margin: soared 32433bps in 2022 and later plummeted -34271bps in 2023.
Year by year, Net Margin stood at 352.07% in 2022, then crashed by -97bps to 9.36% in 2023, then fell by -26bps to 6.9% in 2024, then soared by 96bps to 13.51% in 2025, then skyrocketed by 56bps to 21.11% in 2026.
Business Quant data shows Net Margin for AMGN at 21.11% in Q1 2026, 13.51% in Q4 2025, and 33.65% in Q3 2025.

Peer Comparison